Shiitake Mushroom

Source

A strong 4:1 Shiitake Powder is used to compound for Mymmunity

Ingredient Details

Family‎: ‎Omphalotaceae

Genus‎: ‎Lentinula

Species‎: ‎L. edodes

Immune support

In human research, taking shiitake powder increased signs of immune stimulation, including natural killer cell and T cell activity. Based on saliva immunoglobulin levels, gut immunity was enhanced. Shiitake mushroom contains lentinan which has known immunostimulatory effects. Lentinan appears to enhance T-helper cells and stimulate interferon and various cytokines. It also increases the activity of natural killer cells and macrophages. In laboratory research these same effects may be seen with shiitake mushroom extract.

Other uses

Shiitake is also tonic and adaptogen, to increase energy, cure colds and treat poor circulation.

Other uses include HIV, hepatitis, post surgery immune enhancement and genital warts.

How it works

Shiitake mushroom contains chemicals that might stimulate the immune system. Lentinan is a polysaccharide isolated from the fruit body of shiitake mushroom. Lentinan stimulates the immune system and is used in combination with chemotherapy in the treatment of lung, stomach, skin, breast and colorectal cancer. Lenthionine inhibits platelet aggregation.

Safety

When taken by mouth: Shiitake mushroom is LIKELY SAFE when consumed in food amounts, but it is POSSIBLY UNSAFE in medicinal amounts. It can cause stomach discomfort, blood abnormalities, and skin swelling (inflammation). It might also cause an increased sensitivity to the sun, allergic skin reactions, and breathing problems.

Special Precautions & Warnings:

Pregnancy and breast-feeding: There isn't enough reliable information to know if shiitake mushroom is safe to use when you are pregnant or breast-feeding. Stay on the safe side and avoid use.

"Auto-immune diseases" such as multiple sclerosis (MS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), or other conditions: Shiitake mushroom might cause the immune system to become more active. This could increase the symptoms of auto-immune diseases. If you have one of these conditions, it’s best to avoid using shiitake mushroom.

A blood disorder called eosinophilia: Don't use shiitake mushroom if you have this condition. It might make eosinophilia worse.

Interactions with medications

Medications that decrease the immune system (Immunosuppressants)

Interaction Rating = Moderate Be cautious with this combination.

Talk to your health provider.

Shiitake mushroom seems to increase the activity of the immune system. Therefore, shiitake mushroom might decrease the effectiveness of medications that decrease immune system function.

Some medications that decrease immune system function include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.

Interactions with Herbs, Supplements, and Foods

There are no known interactions with herbs and supplements.

There are no known interactions with foods.

References

The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.

Gordon M, Guralnik M, Kaneko Y, et al. A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3. J Med 1995;26:193-207.

Yoshiyuki T, Onda M, Tokunaga A, et al. [Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port]. Gan To Kagaku Ryoho 1994;21:2323-5.

Tari K, Satake I, Nakagomi K, et al. [Effect of lentinan for advanced prostate carcinoma]. Hinyokika Kiyo 1994;40:119-23.

Nishihira T, Akimoto M, Mori S. [Anti-cancer effects of BRMs associated with nutrition in cancer patients]. Gan To Kagaku Ryoho,1988;15:1615-20.

Wada T, Nishide T, Hatayama K, et al. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer]. Gan To Kagaku Ryoho 1987;14:2509-11.

Kosaka A, Kuzuoka M, Yamafuji K, et al. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans]. Gan To Kagaku Ryoho 1987;14:516-22.

Taguchi T. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect Prev Suppl 1987;1:333-49.

Hitosugi M, Kitamura O, Takatsu A, Yoshino Y. Autopsy case of duodenal obstruction from impacted mushroom. J Gastroenterol 1998;33:562-5.

Hanada K, Hashimoto I. Flagellate mushroom (Shiitake) dermatitis and photosensitivity. Dermatol 1998;197:255-7.

Levy AM, Kita H, Phillips SF, et al. Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998;101:613-20.

Murakami M, Kawabe K, Hosoi Y, et al. Decreased pulmonary perfusion in hypersensitivity pneumonitis caused by Shiitake mushroom spores. J Intern Med 1997;241:85-8.

Matsui S, Nakazawa T, Umegae Y, Mori M. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Intern Med 1992;31:1204-6.

Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis 1992;27:65-70.

Ueda A, Obama K, Aoyama K, et al. Allergic contact dermatitis in shiitake (Lentinus edodes (Berk) Sing) growers. Contact Dermatitis 1992;26:228-33.

Otsuka M, Shinozuka K, Hirata G, Kunitomo M. [Influences of a shiitake (Lentinus edodes)-fructo-oligosaccharide mixture (SK-204) on experimental pulmonary thrombosis in rats]. Yakugaku Zasshi 1996;116:169-73.

Kim HS, Kacew S, Lee BM. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 1999;20:1637-40.

Arinaga S, Karimine N, Takamuku K, et al. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int J Immunopharmac 1992;14:535-539.

Matsuoka H, Seo Y, Wakasugi H, et al. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res 1997;17:2751-5.

Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med 1998;29:305-30.

deVere White RW, Hackman RM, Soares SE, et al. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002;60:640-4..

Nimura, H., Mitsumori, N., Takahashi, N., Kashimura, H., Takayama, S., Kashiwagi, H., and Yanaga, K. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho 2006;33 Suppl 1:106-109.

Sia, G. M. and Candlish, J. K. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytother.Res. 1999;13(2):133-137.

Hamano, K., Gohra, H., Katoh, T., Fujimura, Y., Zempo, N., and Esato, K. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int.J.Immunopharmacol. 1999;21(8):531-540.

Nakano, H., Namatame, K., Nemoto, H., Motohashi, H., Nishiyama, K., and Kumada, K. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology 1999;46(28):2662-2668.

Takemura, T., Takahashi, S., Yoshikawa, T., and Kondo, M. [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. Gan To Kagaku Ryoho 2000;27(1):107-111.

Yamada, T., Watanabe, A., Sadou, S., Nishinuma, T., Tsurui, H., Watanabe, T., and Nakano, H. [A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan]. Gan To Kagaku Ryoho 2000;27(2):281-284.

Hatvani, N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int.J.Antimicrob.Agents 2001;17(1):71-74.

Yoshino, S., Tabata, T., Hazama, S., Iizuka, N., Yamamoto, K., Hirayama, M., Tangoku, A., and Oka, M. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res. 2000;20(6C):4707-4711.

Fujiwara, K., Sato, T., Yonei, T., Genba, K., Nogami, N., and Yamadori, I. [A case of chronic hypersensitivity pneumonitis induced by shiitake mushroom spores]. Nihon Kokyuki.Gakkai Zasshi 2000;38(12):908-913.

Yin, G., Yu, J., and Li, D. [Immune modulatory and therapeutic effect of lentinan on condyloma acuminatum]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1998;18(11):665-667.

Zhang, P. and Cheung, P. C. Evaluation of sulfated Lentinus edodes alpha-(1-->3)-D-glucan as a potential antitumor agent. Biosci.Biotechnol.Biochem. 2002;66(5):1052-1056.

Ng, M. L. and Yap, A. T. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern.Complement Med. 2002;8(5):581-589.

Lippert, U., Martin, V., Schwertfeger, C., Junghans, V., Ellinghaus, B., and Fuchs, T. Shiitake dermatitis. Br.J Dermatol. 2003;148(1):178-179.

Lobanok, A. G., Babitskaia, V. G., Plenina, L. V., Puchkova, T. A., and Osadchaia, O. V. [Composition and biological activity of submerged mycelium of the xylotrophic basidiomycete Lentinus edodes]. Prikl.Biokhim.Mikrobiol. 2003;39(1):69-73.

Ning, J., Zhang, W., Yi, Y., Yang, G., Wu, Z., Yi, J., and Kong, F. Synthesis of beta-(1-->6)-branched beta-(1-->3) glucohexaose and its analogues containing an alpha-(1-->3) linked bond with antitumor activity. Bioorg.Med Chem 5-15-2003;11(10):2193-2203.

Curnow, P. and Tam, M. Contact dermatitis to Shiitake mushroom. Australas.J.Dermatol. 2003;44(2):155-157.

Suzuki, H., Iiyama, K., Yoshida, O., Yamazaki, S., Yamamoto, N., and Toda, S. Structural characterization of the immunoactive and antiviral water-solubilized lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Agric.Biol Chem 1990;54(2):479-487.

Nimura, H., Mitsumori, N., Tsukagoshi, S., Nakajima, M., Atomi, Y., Suzuki, S., Kusano, M., Yoshiyuki, T., and Tokunaga, A. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer]. Gan To Kagaku Ryoho 2003;30(9):1289-1296.

Ngai, P. H. and Ng, T. B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci 11-14-2003;73(26):3363-3374.

Nakayama, H., Aoki, N., Hayashi, S., Wakabayashi, K., Karube, H., Ogame, H., Aoki, H., Sakamoto, N., Masuda, H., and Hemmi, A. [A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma]. Gan To Kagaku Ryoho 2004;31(2):241-243.

Oka, M., Yoshino, S., Hazama, S., Shimoda, K., and Suzuki, T. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion. Biotherapy 1992;5(2):107-112.

Kan, N., Kodama, H., Hori, T., Takenaka, A., Yasumura, T., Kato, H., Ogawa, H., Ohsumi, K., Kudo, N., Mukaihara, S., and . [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group]. Gan To Kagaku Ryoho 1992;19(10 Suppl):1632-1635.

Nagahashi, S., Suzuki, H., Nishiwaki, M., Okuda, K., Kurosawa, Y., Terada, S., Sugihara, T., Andou, K., and Hibi, T. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer]. Gan To Kagaku Ryoho 2004;31(12):1999-2003.

Gu, Y. H. and Belury, M. A. Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes. Cancer Lett 3-18-2005;220(1):21-28.

Kuznetsov, O. I., Mil'kova, E. V., Sosnina, A. E., and Sotnikova, N. I. [Antimicrobial action of Lentinus edodes juice on human microflora]. Zh.Mikrobiol.Epidemiol.Immunobiol. 2005;(1):80-82.

Zheng, R., Jie, S., Hanchuan, D., and Moucheng, W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol. 2005;5(5):811-820.

Mashiko, H., Satoh, J., Hatayama, H., and Kitamura, H. [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. Gan To Kagaku Ryoho 1992;19(5):715-718.

Arinaga, S., Karimine, N., Takamuku, K., Nanbara, S., Nagamatsu, M., Ueo, H., and Akiyoshi, T. Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. Int.J.Immunopharmacol. 1992;14(1):43-47.

Mak, R. K. and Wakelin, S. H. Shiitake dermatitis: the first case reported from a European country. Br J Dermatol 2006;154(4):800-801.

Takahashi, T., Hori, Y., Isogawa, S., Saho, M., Yoshida, H., Yokoyama, K., Watanabe, M., and Nakagawa, S. [A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur]. Gan To Kagaku Ryoho 1990;17(8 Pt 1):1517-1519.

Enman, J., Rova, U., and Berglund, K. A. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). J Agric Food Chem 2-21-2007;55(4):1177-1180.

Yang, P., Liang, M., Zhang, Y., and Shen, B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv.Ther 2008;25(8):787-794.

Sastre, J., Ibanez, M. D., Lopez, M., and Lehrer, S. B. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin.Exp.Allergy 1990;20(1):13-19.

Takeshita, K., Saito, N., Sato, Y., Maruyama, M., Sunagawa, M., Habu, H., and Endo, M. [Diversity of complement activation by lentinan, an antitumor polysaccharide, in gastric cancer patients]. Nippon Geka Gakkai Zasshi 1991;92(1):5-11.

Maekawa, S., Saku, M., Kinugasa, T., Yoshida, Y., Ikejiri, K., and Yakabe, S. [A case report of advanced gastric cancer remarkably responding to mitomycin C, aclacinomycin A, SF-SP and lentinan combination therapy]. Gan To Kagaku Ryoho 1990;17(1):137-140.

Sano, T., Nomura, K., Adachi, M., and Kobori, O. [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. Gan No Rinsho 1990;36(1):97-100.

Shimizu, Y., Chen, J. T., Shiokawa, S., Nakayama, K., Yokosuka, K., Teshima, H., Hirai, Y., Hamada, T., Yamauchi, K., Fujimoto, I., and . [Antigenic phenotype of the lymphocytic component of regional lymph nodes in patients with cervical cancer and its modulation by lentinan]. Nippon Sanka Fujinka Gakkai Zasshi 1990;42(1):37-44.

Tanabe, H., Imai, N., and Takechi, K. [Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer]. Nippon Gan Chiryo Gakkai Shi 8-20-1990;25(8):1657-1667.

Yoshino, S., Oka, M., Hazama, S., and Suzuki, T. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis]. Gan To Kagaku Ryoho 1990;17(8 Pt 2):1588-1591.

Kunitomo, K., Kawahito, M., Miura, M., and Komi, N. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery]. Gan To Kagaku Ryoho 1987;14(5 Pt 1):1342-1344.

Hanaue, H., Tokuda, Y., Machimura, T., Kamijoh, A., Kondo, Y., Ogoshi, K., Makuuchi, H., Nakasaki, H., Tajima, T., Mitomi, T., and . Effects of oral lentinan on T-cell subsets in peripheral venous blood. Clin Ther 1989;11(5):614-622.

Yamamoto, S., Takatori, K., Ohmoto, K., Ideguchi, S., Yamamoto, R., Ohumi, T., Hino, K., and Hirano, Y. [NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use]. Gan To Kagaku Ryoho 1989;16(9):3291-3294.

Miyamoto, K., Inagaki, Y., and Miyairi, M. [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. Nippon Gan Chiryo Gakkai Shi 12-20-1989;24(11):2624-2628.

Yoshino, S., Oka, M., Hazama, S., and Suzuki, T. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation]. Nippon Geka Hokan 5-1-1989;58(3):310-319.

Shimizu, Y., Hasumi, K., Chen, J. T., Hirai, Y., Nakayama, K., Teshima, H., Hamada, T., Fujimoto, I., Yamauchi, K., and Masubuchi, K. [Successful treatment of a patient with recurrent ovarian cancer by lentinan combined with intraarterial 5FU]. Nippon Gan Chiryo Gakkai Shi 3-20-1989;24(3):647-651.

Horiguchi, M., Saito, A., and Sonoda, H. [A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy]. Gan To Kagaku Ryoho 1988;15(6):1973-1977.

Wakui, A., Kasai, M., Konno, K., Abe, R., Kanamaru, R., Takahashi, K., Nakai, Y., Yoshida, Y., Koie, H., Masuda, H., and . [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group]. Gan To Kagaku Ryoho 1986;13(4 Pt 1):1050-1059.

Ishibashi, H., Hirakawa, K., Nakajima, H., Ioka, J., Shirono, K., Tanabe, S., Ochiai, K., Tomita, K., and Kitagawa, Y. [A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan]. Gan To Kagaku Ryoho 1987;14(9):2787-2791.

Peter, G., Karoly, V., Imre, B., Janos, F., and Kaneko, Y. Effects of lentinan on cytotoxic functions of human lymphocytes. Immunopharmacol.Immunotoxicol. 1988;10(2):157-163.

Tochikura, T. S., Nakashima, H., Ohashi, Y., and Yamamoto, N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med.Microbiol.Immunol.(Berl) 1988;177(5):235-244.

Inagaki, T., Morise, K., and Matsunaga, H. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer]. Gan To Kagaku Ryoho 1988;15(2):319-324.

Akimoto, M., Nishihira, T., and Mori, S. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments]. Gan To Kagaku Ryoho 1988;15(4 Pt 2-1):827-833.

Shimizu, H., Inoue, M., Shimizu, C., Saito, J., Ueda, G., and Tanizawa, O. Augmentation of antitumor effect of recombinant interleukin-2 activated killer cells by the administration of rIL-2 and lentinan. Nippon Sanka Fujinka Gakkai Zasshi 1988;40(12):1899-1900.

Nanba, H., Mori, K., Toyomasu, T., and Kuroda, H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull.(Tokyo) 1987;35(6):2453-2458.

Akimoto, M., Nishihira, T., and Kasai, M. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions]. Gan To Kagaku Ryoho 1986;13(4 Pt 2):1270-1276.

Taguchi, T., Furue, H., Kimura, T., Kondo, T., Hattori, T., Itoh, I., and Ogawa, N. [Results of phase III study of lentinan]. Gan To Kagaku Ryoho 1985;12(2):366-378.

Herlyn, D., Kaneko, Y., Powe, J., Aoki, T., and Koprowski, H. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan. Jpn.J.Cancer Res. 1985;76(1):37-42.

Sipka, S., Abel, G., Csongor, J., Chihara, G., and Fachet, J. Effect of lentinan on the chemiluminescence produced by human neutrophils and the murine macrophage cell line C4M phi. Int.J.Immunopharmacol. 1985;7(5):747-751.

Tensho, A., Shimizu, I., Takenawa, T., Kikuchi, H., and Rokujo, T. [Hypocholesterolemic activity of analogous compounds related to eritadenine, an active component of shiitake, Lentinus edodes Sing (author's transl)]. Yakugaku Zasshi 1974;94(6):708-716.

Okuyama, K., Isono, K., Satoh, H., Onoda, S., Ochiai, T., Hayashi, R., Tohnosu, N., Yamamoto, Y., Chin, F., Kimura, M., Ryu, M., Kohzu, T., Odaka, M., and Satoh, H. [Effect of continuous intra-arterial infusion therapy with BLM-MMC-lentinan (B-M-L) in treating patients with hepatic metastases of esophageal cancer]. Nippon Gan Chiryo Gakkai Shi 10-20-1982;17(7):1895-1901.

Miyakoshi, H., Aoki, T., and Mizukoshi, M. Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer. Int.J.Immunopharmacol. 1984;6(4):373-379.

Amino, M., Noguchi, R., Yata, J., Matsumura, J., Hirayama, R., Abe, O., Enomoto, K., and Asato, Y. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients]. Gan To Kagaku Ryoho 1983;10(9):2000-2006.

Taguchi, T. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer]. Gan To Kagaku Ryoho 1983;10(2 Pt 2):387-393.

Suga, T., Shiio, T., Maeda, Y. Y., and Chihara, G. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 1984;44(11):5132-5137.

Fruehauf, J. P., Bonnard, G. D., and Herberman, R. B. The effect of lentinan on production of interleukin-1 by human monocytes. Immunopharmacology 1982;5(1):65-74.

Takeshita, M., Kobori, T., Sudo, E., Miyamoto, Y., and Izuo, M. [Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node]. Gan To Kagaku Ryoho 1982;9(6):1052-1060.

Zakany, J., Chihara, G., and Fachet, J. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer 3-15-1980;25(3):371-376.

Hazama, S., Oka, M., Yoshino, S., Iizuka, N., Wadamori, K., Yamamoto, K., Hirazawa, K., Wang, F., Ogura, Y., Masaki, Y., and . [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma]. Gan To Kagaku Ryoho 1995;22(11):1595-1597.

Sakamaki, S., Kohgo, Y., Suzuki, M., Ogiwara, R., Suga, T., Kondo, N., Izawa, M., Kanisawa, Y., and Niitsu, Y. Individual diversity of IL-6 generation by human monocytes with lentinan administration. Int.J.Immunopharmacol. 1993;15(6):751-756.

Hibino, Y., Konishi, Y., Koike, J., Tabata, T., Ohashi, Y., and Sugano, N. Productions of interferon-gamma and nitrite are induced in mouse splenic cells by a heteroglycan-protein fraction from culture medium of Lentinus edodes mycelia. Immunopharmacology 1994;28(1):77-85.

Mio, H. and Terabe, K. [Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan]. Gan To Kagaku Ryoho 1994;21(4):531-534.

Tani, M., Tanimura, H., Yamaue, H., Tsunoda, T., Iwahashi, M., Noguchi, K., Tamai, M., Hotta, T., and Mizobata, S. Augmentation of lymphokine-activated killer cell activity by lentinan. Anticancer Res. 1993;13(5C):1773-1776.

Ladanyi, A., Timar, J., and Lapis, K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol.Immunother. 1993;36(2):123-126.

Takeshita, K., Watanuki, S., Iida, M., Saito, N., Maruyama, M., Sunagawa, M., Habu, H., and Endo, M. Effect of lentinan on lymphocyte subsets of peripheral blood, lymph nodes, and tumor tissues in patients with gastric cancer. Surg.Today 1993;23(2):125-129.

Matsuoka, H., Yano, K., Seo, Y., Saito, T., Tomoda, H., and Tsurumoto, S. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan. Anticancer Res. 1995;15(5B):2291-2296.

Takeshita, K., Hayashi, S., Tani, M., Kando, F., Saito, N., and Endo, M. Monocyte function associated with intermittent lentinan therapy after resection of gastric cancer. Surg.Oncol. 1996;5(1):23-28.

Mio, H. and Terabe, K. [Clinical effects of postoperative immunochemotherapy with a combination of 5-FU, CDDP and lentinan for stage IVb gastric carcinoma and long-term pharmacokinetic studies on CDDP and 5-FU]. Gan To Kagaku Ryoho 1997;24(3):337-342.

Li, J. F., Guo, J. W., and Huang, X. F. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1996;16(4):224-226.

Yamamoto, Y., Shirono, H., Kono, K., and Ohashi, Y. Immunopotentiating activity of the water-soluble lignin rich fraction prepared from LEM--the extract of the solid culture medium of Lentinus edodes mycelia. Biosci.Biotechnol.Biochem. 1997;61(11):1909-1912.

Takita, M., Onda, M., Tokunaga, A., Shirakawa, T., Ikeda, K., Hiramoto, Y., Teramoto, T., Oguri, T., Fujita, I., Okuda, T., Mizutani, T., Kiyama, T., Yoshiyuki, T., and Matsukura, N. [Successful treatment of hepatic metastasis of gastric cancer with 5'-DFUR and Lentinan]. Gan To Kagaku Ryoho 1998;25(1):129-133.

Liu, M., Li, J., Kong, F., Lin, J., and Gao, Y. Induction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodes. Immunopharmacology 1998;40(3):187-198.

Mizuno, T. Shiitake, Lentinus edodes: functional properties for medicinal and food purposes. Food Rev.Int. 1995;11:111-128.

Wong, G. Y. C., Katdarae, M., Osborne, M. P., and Telang, N. T. Preventative efficacy of Lentinus edodes mycelium extract (LEM) in human mammary carcinogenesis (abstract 321). 19th Annual San Antonio Breast Cancer Symposium, (San Antonio, Texas) 1996;265.

Jones, K. Shiitake: A Major Medicinal Mushroom. Alternative and Complementary Therapies 1998;4(1):53-59.

Ade R, Sukut C, Wiser HJ, Shockman S, Buescher L. Shiitake dermatitis demonstrating Köebner phenomenon. Int J Dermatol. 2015;54(5):e179-81.

Adler MJ, Larsen WG. Clinical variability of shiitake dermatitis. J Am Acad Dermatol. 2012 Oct;67(4):e140-1.

Adriano AR, Acosta ML, Azulay DR, Quiroz CD, Talarico SR. Shiitake dermatitis: the first case reported in Brazil. An Bras Dermatol. 2013 May-Jun;88(3):417-9.

Ampere A, Delhaes L, Soots J, Bart F, Wallaert B. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol. 2012 Aug;50(6):654-7.

Baran W, Batycka-Baran A, Maj J, Szepietowski JC. Shiitake dermatitis - now also in Poland. Acta Derm Venereol. 2015 Jan;95(1):102-3.

Boels D, Landreau A, Bruneau C, et al. Shiitake dermatitis recorded by French Poison Control Centers - new case series with clinical observations. Clin Toxicol (Phila). 2014 Jul;52(6):625-8.

Chu EY, Anand D, Dawn A, Elenitsas R, Adler DJ. Shiitake dermatitis: a report of 3 cases and review of the literature. Cutis. 2013 Jun;91(6):287-90.

Corazza M, Zauli S, Ricci M, et al. Shiitake dermatitis: toxic or allergic reaction? J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1449-51.

Czarnecka AB, Kreft B, Marsch WCh. Flagellate dermatitis after consumption of Shiitake mushrooms. Postepy Dermatol Alergol. 2014 Jun;31(3):187-90.

Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. J Am Coll Nutr. 2015;34(6):478-87.

Hamer SE, Kulkarni K, Cohen SN. Shiitake dermatitis with oral ulceration and pustules. Clin Exp Dermatol. 2015 Apr;40(3):332-3.

Hiernickel C, Metz S, Elsner P. Shiitake dermatitis: an impressive case report. J Dtsch Dermatol Ges. 2015 May;13(5):455-6.

Karanovic S, George S, Topham E. Don't miss shiitake dermatitis: a case report. Br J Gen Pract. 2014 Aug;64(625):426-7.

Kopp T, Mastan P, Mothes N, Tzaneva S, Stingl G, Tanew A. Systemic allergic contact dermatitis due to consumption of raw shiitake mushroom. Clin Exp Dermatol. 2009 Dec;34(8):e910-3.

Lingström P, Zaura E, Hassan H, et al. The anticaries effect of a food extract (shiitake) in a short-term clinical study. J Biomed Biotechnol. 2012;2012:217164.

Loo HV, Oon HH. Flagellate dermatitis following consumption of shiitake mushroom. Dermatol Reports. 2011 Oct 5;3(2):e21.

Luber AJ, Ackerman LS. Flagellate shiitake mushroom dermatitis. Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt7rm57553.

Mendonça CN, Silva PM, Avelleira JC, Nishimori FS, Cassia Fde F. Shiitake dermatitis. An Bras Dermatol. 2015 Mar-Apr;90(2):276-8.

Netchiporouk E, Pehr K, Ben-Shoshan M, Billick RC, Sasseville D, Singer M. Pustular flagellate dermatitis after consumption of shiitake mushrooms. JAAD Case Rep. 2015 May 2;1(3):117-9.

Nguyen AH, Gonzaga MI, Lim VM, Adler MJ, Mitkov MV, Cappel MA. Clinical features of shiitake dermatitis: a systematic review. Int J Dermatol. 2017 Jun;56(6):610-616.

Poppe LM, Anders D, Kneitz H, Bröcker EB, Benoit S. Flagellate dermatitis caused by shiitake mushrooms. An Bras Dermatol. 2012 May-Jun;87(3):463-5.

Pravettoni V, Primavesi L, Piantanida M. Shiitake mushroom (Lentinus edodes): a poorly known allergen in Western countries responsible for severe work-related asthma. Int J Occup Med Environ Health. 2014 Oct;27(5):871-4.

Ricar J, Pizinger K, Cetkovska P. Shiitake dermatitis: a distinctive clinical entity. Int J Dermatol. 2013 Dec;52(12):1620-1.

Shozushima M, Ohata K, Nonaka K, Matsuhashi N. Shiitake mushroom-induced ileus managed using double-balloon enteroscopy. Endoscopy. 2013;45 Suppl 2 UCTN:E437.

Uslu U, Linkner RV. Shiitake mushroom dermatitis. Cutis. 2015 May;95(5):E11-2.

Wang AS, Barr KL, Jagdeo J. Shiitake mushroom-induced flagellate erythema: A striking case and review of the literature. Dermatol Online J. 2013 Apr 15;19(4):5.

Laurino LF, Viroel FJM, Caetano E, et al. Lentinus edodes exposure before and after fetus implantation: materno-fetal development in rats with gestational diabetes mellitus. Nutrients 2019;11(11):2720. doi: 10.3390/nu11112720.

Tan J, Yuan K, Zuo J, et al. Two cases of small bowel obstruction due to a shiitake mushroom. Gastroenterol Rep (Oxf) 2019;7(4):298-300. doi: 10.1093/gastro/gox028.